Cinde Warmington secured the Democratic nomination for New Hampshire governor while facing renewed scrutiny over her legal work for Purdue Pharma, the company that aggressively marketed prescription opioids.
Warmington's past representation of the pharmaceutical company has drawn criticism from rival candidates and progressive groups during her campaign for the state's top office.
